These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 18768109)

  • 1. Effects of colchicine on strength-duration properties of sensory and motor axons.
    Yerdelen D; Koc F; Uysal H
    Neurol Res; 2009 Apr; 31(3):300-3. PubMed ID: 18768109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strength-duration properties of sensory and motor axons in alcoholic polyneuropathy.
    Yerdelen D; Koc F; Uysal H
    Neurol Res; 2008 Sep; 30(7):746-50. PubMed ID: 18489821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of hyperventilation on strength-duration properties in diabetic polyneuropathy.
    Yerdelen D; Uysal H; Koç F; Sarica Y
    Clin Neurophysiol; 2007 Jan; 118(1):105-10. PubMed ID: 17095293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latent addition in human motor and sensory axons: different site-dependent changes across the carpal tunnel related to persistent Na+ currents.
    Kuwabara S; Misawa S; Tamura N; Nakata M; Kanai K; Sawai S; Ogawara K; Hattori T
    Clin Neurophysiol; 2006 Apr; 117(4):810-4. PubMed ID: 16497550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strength-duration properties and excitability of motor and sensory axons across different target thresholds.
    Shimatani Y; Lin CS; Matamala JM; Kiernan MC
    J Neurophysiol; 2023 Jun; 129(6):1434-1446. PubMed ID: 37162078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy.
    ; ; . PubMed ID: 19745023
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.